Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

Sapio Andrew Wyatt

Sapio Sciences and Zifo forge alliance to enhance laboratory informatics

, 23 September 2024/in E-News /by panglobal

In a move set to enhance lab data management, Sapio Sciences and Zifo have announced a strategic partnership aimed at delivering cutting-edge laboratory information management solutions to the life sciences sector. The collaboration promises to merge Sapio’s science-aware™ lab informatics platform with Zifo’s expertise in scientific informatics services.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/Sapio-Andrew-Wyatt.jpg 1920 1849 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:30:582024-09-23 11:30:58Sapio Sciences and Zifo forge alliance to enhance laboratory informatics
Eva van Rikxoort

Thirona divests retinal AI division to Revenio Group

, 23 September 2024/in E-News /by panglobal

Thirona, a Dutch company specialising in AI-powered medical lung image analysis, has announced the sale of its Thirona Retina BV division to Icare Finland Oy, a subsidiary of Revenio Group Corporation. This strategic move, finalised on 20 August 2024, allows Thirona to concentrate on its core focus of pulmonary diseases and interventional pulmonology, while positioning […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/Eva-van-Rikxoort.jpg 942 732 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:27:222024-09-23 11:27:22Thirona divests retinal AI division to Revenio Group
osteolabs

Calcium isotope marker technology shows promise for early osteoporosis detection

, 23 September 2024/in E-News /by panglobal

German diagnostic company osteolabs GmbH has published groundbreaking real-world evidence data from nearly 3,000 patient samples, demonstrating the potential of their proprietary Calcium Isotope Marker (CIM) technology in early osteoporosis risk assessment. The study, published in the journal Bone, [1] marks a significant advancement in the field of metabolic bone disease diagnostics.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/osteolabs.jpg 1446 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:24:502024-09-23 11:24:50Calcium isotope marker technology shows promise for early osteoporosis detection
uniqsis24 09a

Asynt acquires flow chemistry specialist Uniqsis

, 23 September 2024/in E-News /by panglobal

In a strategic move to expand its chemistry technology portfolio, Asynt Ltd has completed the acquisition of flow chemistry specialist Uniqsis. The deal, finalised on 31 August 2024, encompasses the transfer of all Uniqsis staff, intellectual property, and equipment stock.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/uniqsis24-09a.png 339 465 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:22:332024-09-23 11:22:33Asynt acquires flow chemistry specialist Uniqsis
Chris Gibson

Recursion and Exscientia to merge, creating AI-driven drug discovery powerhouse

, 23 September 2024/in E-News /by panglobal

In a significant move set to reshape AI-driven drug discovery, Recursion and Exscientia have announced an agreement to combine their operations. The merger, expected to close by early 2025, aims to create a global technology-enabled drug discovery leader with end-to-end capabilities.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/Chris-Gibson.jpg 944 940 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:20:232024-09-23 11:20:23Recursion and Exscientia to merge, creating AI-driven drug discovery powerhouse
vapourtec 24 09

Vapourtec and Accelerated Materials collaborate to enhance automated chemistry efficiency

, 23 September 2024/in E-News /by panglobal

In a significant development for the field of flow chemistry, engineering specialists Vapourtec have announced a collaboration with Accelerated Materials to expand the application of machine learning (ML) in chemical optimisation processes. This partnership aims to improve the efficiency and accuracy of predictive modelling in flow chemistry, a technique increasingly utilised in pharmaceutical research and […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/vapourtec_24-09.jpg 360 1226 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:17:492024-09-23 11:17:49Vapourtec and Accelerated Materials collaborate to enhance automated chemistry efficiency
SGS Govender

SGS expands specialised bioanalytical testing services to North American market

, 23 September 2024/in E-News /by panglobal

SGS, a global leader in testing, inspection, and certification, has announced the introduction of new specialised bioanalytical testing services for the North American pharmaceutical and biopharmaceutical markets. This expansion marks a significant development in the company’s capabilities to support drug development processes across various clinical trial phases.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/SGS-Govender.jpg 946 832 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:14:492024-09-23 11:14:49SGS expands specialised bioanalytical testing services to North American market
biolyst

Electron Microscopy Sciences and Azer Scientific merge to form Biolyst Scientific

, 23 September 2024/in E-News /by panglobal

In a significant development for the life sciences sector, Electron Microscopy Sciences (EMS) and Azer Scientific have merged to form Biolyst Scientific. The new company has an extensive portfolio of over 30,000 products spanning microscopy, histology, and other research domains.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/biolyst.jpg 1280 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:10:532024-09-23 11:10:53Electron Microscopy Sciences and Azer Scientific merge to form Biolyst Scientific
ventrilabs

Novel gravity-based pump technology promises gentler handling of biological fluids

, 23 September 2024/in E-News /by panglobal

Ventri Labs AB, a new subsidiary of Biotech Fluidics, has unveiled an innovative pump technology that could revolutionise the handling of sensitive biological materials in medical and research applications.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/ventrilabs.jpg 624 936 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:07:582024-09-23 11:07:58Novel gravity-based pump technology promises gentler handling of biological fluids
Scherm­afbeelding 2024 09 23 om 12.42.47

International consortium aims to revolutionise viral vector manufacturing

, 23 September 2024/in E-News /by panglobal

A groundbreaking collaboration between leading biotechnology companies and research organisations in the UK and Canada has secured £1.1 million in funding to develop a next-generation cell platform for viral vector production. The project, led by VVector Bio and including the National Research Council of Canada (NRC), Revvity, and Abselion, aims to address critical bottlenecks in […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/09/Scherm­afbeelding-2024-09-23-om-12.42.47.jpg 494 1014 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-09-23 11:04:532024-09-23 11:04:53International consortium aims to revolutionise viral vector manufacturing
Page 19 of 228«‹1718192021›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
15 December 2025

WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

13 December 2025

Indero validates three-day gene expression method

12 December 2025

Johnson & Johnson acquires Halda Therapeutics for $3.05 billion

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription